Limbic Encephalitis
Recent clinical, regulatory, research and industry developments relating to this disease.
Ageing-Related Neurodegeneration and Cognitive Decline.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes6
- Alzheimer Disease1
- Cognitive Dysfunction1
- Lewy Body Disease1
- Limbic Encephalitis1
- Synucleinopathies1
- Tauopathies1
Leading journals1
- International journal of molecular sciences1
Leading researchers2
- Alafuzoff I1
- Libard S1
Affiliations (unnormalised)2
- Uppsala University1
- Uppsala University Hospital1
Reference
Authoritative identity, definition & identifiers.
A paraneoplastic syndrome marked by degeneration of neurons in the LIMBIC SYSTEM. Clinical features include HALLUCINATIONS, loss of EPISODIC MEMORY; ANOSMIA; AGEUSIA; TEMPORAL LOBE EPILEPSY; DEMENTIA; and affective disturbance (depression). Circulating anti-neuronal antibodies (e.g., anti-Hu; anti-Yo; anti-Ri; and anti-Ma2) and small cell lung carcinomas or testicular carcinoma are frequently associated with this syndrome.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.